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Abstract 
Background: Chronic rhinosinusitis (CRS) describes an inflammatory condition affecting the sinonasal mucosa. As 
the immune system players such as immunoglobulins play prominent roles in the development of CRS, we aimed to 
investigate the expression of IgA subclasses and factors involved in IgA class switching in the sinonasal mucosa of CRS 
patients.
Methods: Specimens were collected from the sinonasal mucosa of the healthy controls and CRS patients. 
Histological assessments were performed by H&E and immunohistochemistry. Real-time PCR and ELISA methods 
were applied to measure gene expression and protein levels extracted from tissue samples, respectively.
Results: We observed that total IgA and subclass-positive cells were higher in the patient groups than controls. 
There was a significant correlation between the number of eosinophils and total IgA and subclasses-positive cells 
(Pv < 0.0001). The expression of CXCL13, BAFF, AID, and germline transcripts were increased in CRSwNP patients. In 
contrast to IgA2 levels, IgA1 levels were significantly increased in the sinonasal tissue of CRSwNP patients (Pv < 0.01). 
TGF-β was significantly elevated in the sinonasal tissue of patients with CRSsNP.
Conclusions: Increased protein levels of IgA subclasses and related antibody-producing cells were associated with 
elevated eosinophils in CRSwNP patients which may result in eosinophil pathological functions. Several therapeutic 
approaches might be developed to modulate the IgA production to ameliorate the inflammatory mechanisms in 
CRSwNP patients.
Keywords: CRSsNP, CRSwNP, B cell, IgA, Class switching, Nasal polyps, Chronic rhinosinusitis
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Open Access
Allergy, Asthma & Clinical Immunology
*Correspondence:  falak.r@iums.ac.ir
1 Department of Immunology, School of Medicine, Iran University 
of Medical Sciences, Tehran, Iran
Full list of author information is available at the end of the article
Background
Chronic rhinosinusitis (CRS) refers to a chronic 
condition associated with local inflammation of sinonasal 
airways [1]. Based on the signs and symptoms, CT and 
endoscopic criteria, CRS is divided into two main groups, 
including CRS with nasal polyps (CRSwNP) and CRS 
without nasal polyps (CRSsNP) [2, 3]. Although the 
exact etiology of CRS remains unknown, immunological 
mechanisms are suspects in its initiation and progression.
Immunoglobulins (Igs) are major players of humoral 
immunity against infectious agents. The mucosa of 
sinonasal tracts encounters various microbes; therefore, 
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IgA may play a protective role in response to sinonasal 
pathogenic microbes [4, 5]. IgA is the main secretory 
antibody found in mucosal surfaces and fluids which is 
produced by mucosal plasma cells and is translocated 
to the tracts of mucosal sites [6]. IgA1 and IgA2, as the 
most important isotypes of IgA in human beings, display 
distinct expression patterns in different mucosal tissues. 
IgA1 is dominantly expressed in airway tracts whereas 
IgA2 is predominantly found in secretions of the large 
intestine. However, both isotypes are approximately 
expressed in equal concentrations in the small intestine 
[7].
IgA is produced by B cells upon cytokine- and 
chemokine-stimulation provided by local inflammatory 
cells [8]. In this regard, some factors such as B cell–
Activating Factor of the TNF family (BAFF, also named 
BLyS) and A Proliferation Inducing Ligand (APRIL) play 
pivotal roles in the maturation as well as the survival of 
B cells and plasma cells [9]. Moreover, they promote IgA 
class switching in a T cell-independent manner [10, 11].
Conversely, TGF-β is another cytokine produced by 
a variety of cell types, including fibroblasts and helper 
T cells. In fact, it is involved in T cell-dependent IgA 
class switching by regulation of germline transcripts 
[12–14]. In other words, Iα1-Cα1 and Iα2-Cα2 
germline transcripts are produced by transcription of 
un-rearranged constant heavy chain (CH) genes through 
class switching to IgA subclasses [15]. Class switching 
occurs at constant regions of antibodies and is mainly 
performed by Activation Induced Cytidine Deaminase 
(AID) enzyme in activated B cells [16]. AID is normally 
expressed in germinal center B cells of lymphoid 
organs and mucosal tissues. Some distinct sequences 
of DNA, named as switch (S) regions, are located at the 
upstream of the Ig isotype genes (except for IgD). Upon 
the proximity of donor and acceptor in S region, DNA 
is broken and the formerly rearranged V domains of Ig 
heavy-chains are expressed in association with a different 
C region instead of initial Cµ, thus class switching to IgA, 
IgG, or IgE isotypes occur [17].
Another aspect of class switching is comprised of 
circular DNA deletion, so-called Switch Circles (SC), 
from the Ig heavy-chain loci through recombination. 
Switch circles consist of the DNA composition between 
the Sµ and a downstream S region as well as Intervening 
(I) region promoter located at the upstream of Sµ. Under 
the control of the I promoter, the SC produces an Iα–Cµ 
transcript, named circle transcript which contributes 
to AID in order to show ongoing class switching [18]. 
However, the process of local class switching to IgA 
subclasses is not fully determined in CRS patients. 
Therefore, we aimed to investigate the expression of IgA 
subclasses and also factors involved in the promotion 




Patients suffering from CRS were recruited from the 
ENT, head, and neck clinic at Rasoul Akram Hospital, 
IUMS. A total of 36 CRSwNP patients and 12 CRSsNP 
patients took part in the study. Control inferior turbinate 
tissues (n = 22) were collected from subjects undergoing 
rhino-septoplasty as a result of septum deviation 
without a history of asthma or CRS. Demographic data 
of all participants are listed in Table  1. Nasal polyps 
was diagnosed based on the endoscopy and CT scan 
results, corresponding to the European Position Paper 
on Rhinosinusitis and Nasal Polyps [19]. This study 
was approved by the ethics committee of IUMS (IR.
IUMS.FMD.REC1394.9211127203) and all participants 
filled written informed consent for tissue sample 
gathering. CRS patients who had immunodeficiencies, 
cystic fibrosis, bronchiectasis, chronic obstructive 
pulmonary disease, diabe-tes mellitus, neoplasia, fungal 
rhinosinusitis, upper airway infections within 1  month 
were excluded from the study. None of the participants 
were preg-nant or have been lactating; or used systemic 
or local corticosteroids, antihistamines, decongestants, 
antibiotics, and anti-leukotrienes within 4 weeks prior to 
surgery.
Biopsies and specimens
Tissue samples were obtained from ethmoid mucosa 
and cut into three pieces; two sections were immediately 
stored at −80  °C for RNA and protein extractions. 
The third section was fixed overnight in a freshly 
prepared fixative containing 4% paraformaldehyde in 
PBS (pH 7.4) and finally embedded in paraffin wax for 
immunohistochemistry (IHC) tests.
Table 1 Characteristics of CRS patients and controls
CT Score Computed tomography score, IQR Interquartile range, CRSsNP Chronic 
rhinosinusitis without nasal polyps, CRSwNP Chronic rhinosinusitis with nasal 
polyps, VAS score Visual analogue scale score
Characteristics Controls CRSsNP CRSwNP
Number 22 12 36
Females/males 8/14 4/8 12/24
Age (y), median (IQR) 28 (24.7–33) 28 (17.2–36) 34.5 (30–41.7)
Asthma – – 8
CT score – 7.5±5 14.3±6.6
Endoscopic score – 0.7±0.6 1.9±0.7
VAS score – 5.6±2.5 8.9±3
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Histologic analysis
Tissue slides were prepared from the paraffin-embedded 
tissues and subsequently 3  μm sections stained by 
Hematoxylin & Eosin (H&E) to study the pathologic 
features of the samples. The frequency of eosinophils, 
neutrophils, mononuclear cells, total inflammatory cells, 
goblet cells, and mucosal glands was determined using 
an Olympus CX-40 light microscope (Olympus, Tokyo, 
Japan) with high power field (HPF:400X) and 5 random 
HPFs were evaluated by two independent pathologists 
who were blind to the clinical information. The data were 
presented as cells or glands per HPF. We also divided 
CRSwNP patients into two subgroups, one subgroup 
was defined as eosinophilic when eosinophils comprised 
more than 10% of the total inflammatory cells–as the 
cut-off–and another subgroup was defined as non-
eosinophilic when eosinophils were less than 10% of the 
total inflammatory cells [20].
Immunohistochemistry
In brief, sinonasal tissues were dehydrated and embedded 
in the paraffin and sectioned at 3  µm diameters. After 
rehydration and blocking of the endogenous peroxidase 
activity with 3%  H2O2/methanol, the sections were 
washed with Tris-buffered saline (TBS) and blocked 
(with PBS, pH 7.4, containing 2% bovine serum albumin 
(Sigma-Aldrich, Darmstadt, Germany), 0.1% Triton 
X-100, and 0.1% sodium azide) at room temperature 
(RT) to reduce nonspecific bindings for 30  min to 
hinder nonspecific binding [21]. Then, the sections 
were incubated with an appropriate concentration of 
the antibodies for 1 h at RT. The details of which are as 
follows: primary antibodies, including polyclonal rabbit 
anti-human IgA antibody (at 1:100 dilution; Abcam, 
Cambridge, MA, USA), anti-human IgA1 antibody (at 
1:200 dilution; ab193187), anti-human IgA2 antibody 
(1:100; ab193169, Abcam), monoclonal mouse anti-
human CD20 (at 1:200 dilution; clone L26, Dako, 
Glostrup, Denmark), anti-human CD138 (1:100; Clone 
M115) were applied. After 2  h incubation, the slides 
were washed with TBS for 10  min and again incubated 
for 45 min at 30 °C with EnVision™ (Dako). The samples 
were coun-terstained with Mayer’s hematoxylin stain 
and mounted in Faramount Mounting Medium (Dako), 
before microscopic examination.
Quantitative real‑time polymerase chain reaction
Total RNA was isolated from nasal tissues with Trizol 
(Invitrogen, USA) according to the manufacturer’s 
instructions and the integrity of RNA was controlled by 
electrophoresis on 2% denaturing agarose gel. The minor 
genomic DNA contaminations were then removed by 
RNase-free DNase Set (Qiagen, Chatsworth, CA, USA) 
and 500 ng of total RNA from each sample was subjected 
to first-strand cDNA synthesis using RevertAid™ First 
Strand cDNA Synthesis Kit (MBI, Fermentas, USA). 
The success of the reverse transcription reaction was 
monitored by PCR amplification of glyceraldehyde-3-
phosphate dehydrogenase transcripts. Real-time PCR 
reactions were carried out in total 20 µL volumes in 
Rotor-Gene Q machine (Qiagen, Hilden, Germany), 
using 10 µL of 2 × SYBR Green Master Mix (Takara), 
1 µL of cDNA, and 1 µL of 200 nM mixture of forward 
and reverse primers in duplicate. The primer sequences 
are listed in Table  2. The temperature profile included 
40 PCR cycles with 95 °C denaturation for 5 s and 60 °C 
annealing and extension for 30  s. The mean threshold 
cycle values were normalized to the expression of beta-
actin (β-actin) and the relative mRNA expression levels 
of target genes were calculated using  2−ΔΔCt method.
Measurement of immunoglobulins and cytokines
The biopsies were weighed and homogenized in a pre-
cooled pestle and mortar with an appropriate amount 
of ice-cold PBS supplemented with 0.05% Tween 20 
(Sigma-Aldrich, St Louis, Mo, USA) and 1% cocktail of 
protease inhibitors (Santa Cruz, California, USA). In 
brief, 1 μL of buffer added per 1 mg of the tissue, upon 
homogenization the content was centrifuged at 4000g 
for 20  min at 4  °C. Supernatants were aliquoted and 
stored at −80 °C. Total IgA was measured by Minineph™ 
human IgA kit (ZK010.R, Birmingham, UK) using 
Minieph nephelometry instrumentation (Binding Site, 
UK). We used sandwich ELISA kits for measurement of 
Table 2 Primers used for quantitative PCR
Primers Forward and reverse sequences
μ GLT F: 5’-GTG ATT AAG GAG AAA CAC TTT GAT -3’
R: 5’-AGA CGA GGG GGA AAA GGG TT-3’
α1 GLT F: 5’-CTC AGC ACT GCG GGC CCT CCA-3’
R: 5’-GTT CCC ATC TGG CTG GGT GCT GCA -3’
α2 GLT F: 5’-CTC AGC ACT GCG GGC CCT CCA-3’
R: 5’-GTT CCC ATC TTG GGG GGT GCT GTC -3’
Iα-Cμ F: 5’-CAG CAG CCC TCT TGG CAG GCA GCC AG-3’
R: 5’-AGA CGA GGG GGA AAA GGG TT-3’
AID F: 5’-CAC CAC TAT GGA CAG CCT CTTG-3’
R: 5’-ACT GTC ACG CCT CTT CAC TACG-3’
BAFF 5’-TGC CTG AAA CAC TAC CCA ATAA-3’
R: 5’-AGC AGT TTC AAT GCA CCA AA-3’
APRIL F: 5’-GCC AGG TCC TGT TTC AAG ACGT-3’
R: 5’-TGT AAA TGG AAG ACA CCT GCGC-3’
CXCL13 F: 5’-GCT TGA GGT GTA GAT GTG TCC-3’
R: 5’-CCC ACG GGG CAA GAT TTG AA-3’
β-actin F: 5’-TCC CTG GAG AAG AGC TAC G-3’
R: 5’-GTA GTT TCG TGG ATG CCA CA-3’
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IgA subclasses, including IgA1 and IgA2 (MyBioSource, 
San Diego, USA) and for determination of the active 
form of TGF-β1 (R&D Systems, Minneapolis, USA) 
according to manufacturers’ instructions The minimum 
detectable amount of the applied kits was 28 ng/ml, 4 ng/
ml, and 31 pg/ml for IgA1, IgA2, and TGF-β, respectively. 
The total protein of the extracts was measured with 
BCA method (Bio-Rad, Hercules, California) and the 
concentrations of total IgA, IgA1, IgA2, and TGF-β in the 
lysates were normalized to the protein concentrations.
Statistical analysis
Statistical analysis was performed with SPSS version 
24.0 (SPSS Inc., Chicago, Illinois, USA) and plots were 
depicted by Prism version 6.1 software (GraphPad, La 
Jolla, California). Kolmogorov–Smirnov test was used to 
evaluate the normal distribution of the data. Data were 
expressed as medians and interquartile ranges (IQR) 
unless otherwise noted, and statistical significance was 
analyzed using nonparametric Mann–Whitney U test 
to determine intergroup differences and Kruskal–Wallis 
H for evaluation of the differences between groups. 
The Spearman test was used to determine correlations 
between cellular frequencies. P-values less than 0.05 were 
considered statistically significant.
Results
In this study 22 controls (8 females and 14 males), 
12 CRSsNP patients (4 females and 8 males) and 
36 CRSwNP patients (12 females and 24 males) 
participated. The median (IQR) age of the participants 
was 28 (24.7–33), 28 (17.2–36) and 34.5 (30–41.7), 
respectively. The comparison of the endoscopic score, 
CT score, and VAS score of the CRS patients with 
controls are summarized in Table 1.
The number of inflammatory cells was increased in CRS 
patients
Evaluation of H&E stained slides showed that 
CRS patients had higher eosinophils than controls 
(P < 0.001). There was no significant difference between 
the eosinophil count of CRSsNP and CRSwNP groups 
(Fig. 1 and Table 3). The frequency of neutrophils was 
significantly higher in CRSwNP and CRSsNP groups 
than controls (P < 0.001 and P = 0.023, respectively). 
There was no significant difference between neutrophil 
count of CRSsNP and CRSwNP groups (Table  3). The 
number of total inflammatory cells was significantly 
higher in both CRS groups and there was also a 
significant difference between CRSwNP and CRSsNP 
groups (P < 0.001 for CRSwNP vs controls, P = 0.031 
for CRSsNP vs controls and P = 0.002 for CRSsNP vs 
CRSwNP). 
The number of eosinophils correlated with IgA producing 
cells
The number of  CD20+ cells (a marker of naive B cells) 
was elevated in CRS patients in comparison to controls 
(P < 0.001 and P = 0.001, respectively), but there was no 
significant difference between CRSsNP and CRSwNP 
groups. The frequency of  CD138+ cells (a marker of 
plasma cells) was increased in CRSwNP patients in 
comparison to CRSsNP and controls (P = 0.009 and 
P < 0.001, respectively). Total  IgA+ cells were elevated in 
the lamina propria (LP) of both CRS patients compared 
with controls (P < 0.001). However, the evaluation of 
total  IgA+ cells in the epithelium (EP), only revealed 
a difference in the CRSwNP patients and controls 
(P = 0.002). The number of  IgA1+ and  IgA2+ cells in the 
LP and  IgA1+ cells in the EP of CRS patients was higher 
than the controls. In contrast, there was no significant 
difference in the frequency of  IgA2+ cells in the EP of 
CRSwNP and CRSsNP groups (Table  4). Notably, the 
number of infiltrating eosinophils significantly correlated 
with the total IgA expressing cells and also IgA subtypes 
expressing cells in LP of CRSwNP patients (P < 0.0001) 
(Fig. 2).
IgA positive cells were increased in ENP subgroup
According to the proportion of eosinophils to total 
inflammatory cells [20], we divided CRSwNP patients 
into 23 eosinophilic CRSwNP (ENP) and 13 non-
eosinophilic CRSwNP (N-ENP) subgroups. ENP patients 
had higher neutrophils than N-ENP and we observed 
only a significant difference between neutrophil count 
of ENP and CRSsNP patients (P = 0.005). We found 
that total inflammatory cells in the ENP patients were 
significantly higher than N-ENP patients (Table  5). The 
number of  CD20+ cells was significantly increased in 
the sinonasal mucosa of ENP in comparison to CRSsNP 
patients (P = 0.026). In addition, the frequency of plasma 
cells was significantly elevated in the ENP subgroup 
compared with N-ENP and CRSsNP patients (P = 0.022 
and P = 0.01, respectively). Total  IgA+ cells were elevated 
in the LP and EP of ENP subgroup compared with 
N-ENP and CRSsNP patients. The number of  IgA1+ cells 
in the LP and  IgA2+ cells in the EP was enhanced in ENP 
patients compared with N-ENP patients. The frequency 
of  IgA2+ cells in the LP of ENP patients was increased in 
comparison to N-ENP and CRSsNP patients. There was 
no significant difference between the number of  IgA1+ 
cells of EP among ENP, N-ENP, and CRSsNP patients 
(Table 6).
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BAFF, CXCL13, and GLTs were increased in CRSwNP 
patients
The expression level of BAFF, IαCµ, and CXCL13 was 
significantly increased in CRSwNP patients compared 
with controls (Pv < 0.01) and no significant difference 
was observed between CRSsNP and CRSwNP groups 
(Fig.  3). It was also revealed that mRNA expression of 
Iα1Cα1, Iα2Cα2, and µGLT was significantly elevated in 
Fig. 1 The inflammatory pattern of sinonasal tissues. a H&E staining and b IHC staining related to  CD20+ (representing B cells),  CD138+ 
(representing plasma cells), total  IgA+,  IgA1+, and  IgA2+ cells (indicating IgA producing cells); in healthy controls and CRS patients. Scale bar 
100 µm. CRSsNP Chronic rhinosinusitis without nasal polyps, CRSwNP Chronic rhinosinusitis with nasal polyps
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CRSwNP patients (Pv < 0.05) and no significant difference 
was observed between CRSsNP and CRSwNP groups 
(Fig.  3). The expression level of AID was significantly 
different between CRSwNP patients and both CRSsNP 
patients (Pv < 0.05) and controls (Pv < 0.01). Conversely, 
no difference was observed in terms of APRIL expression 
among the three groups (Fig. 3).
Total IgA and IgA1 were increased in CRSwNP patients
The protein level of total IgA and IgA1 were significantly 
higher in CRSwNP patients than in other groups (Fig. 4). 
However, no difference was found in the IgA2 level of the 
studied groups (Fig. 4). The concentration of TGF-β was 
significantly increased in CRSsNP patients (Figure  4). 
Furthermore, the level of total IgA, IgA1 and IgA2 in 
ENP group were significantly higher than N-ENP group 
(Fig. 5).
Discussion
Since the definitive mechanisms underlying IgA class 
switching in CRS patients are not completely understood, 
we evaluated the levels of total IgA and IgA subclasses 
as well as the involved mechanisms of IgA1 and IgA2 
isotype switching in CRS patients and controls. Indeed, 
we evaluated inflammatory patterns of CRS patients 
and the protein levels of total IgA and IgA subclasses 
in addition to the expression levels of APRIL, BAFF, 
Iα1-Cα1GLT, Iα2-Cα2 GLT, μGLT, Iα–Cµ CT, AID, and 
CXCL13.
CRSwNP patients exhibited dominant eosinophilic 
inflammation in western populations but Chinese nasal 
polyps mostly exhibited non-eosinophilic inflammation 
[2]. Our results showed that 64% of CRSwNP patients 
were eosinophilic (ENP) and 36% were non-eosinophilic 
(N-ENP). Luo et  al. showed that eosinophil infiltration 
had a direct correlation with disease severity and a higher 
CT and endoscopic scores. Their results suggested that 
eosinophilic status is associated with poor prognosis 
and long disease duration [22]. It has been demonstrated 
that eosinophils play pivotal roles in the pathogenesis 
Table 3 General histologic results of control, CRSsNP, and CRSwNP groups
Values are expressed as medians (IQR). The Mann-Whitney U test was used for unpaired comparisons
CRSsNP Chronic rhinosinusitis without nasal polyps, CRSwNP Chronic rhinosinusitis with nasal polyps
P < 0.05 was considered statistically significant. Italics P values show significant results (<0.05)






Neutrophils 0.5 (0.5–1.5) 2 (1–4.5) 5 (2.5–9.25) 0.023 <0.001 0.85
Eosinophils 0.5 (0.5–1) 11.5 (4.5–17.5) 23.25 (6.75–36) < 0.001 < 0.001 0.1
Mononuclear cells 9.5 (6–13) 13.5 (8.5–19) 26 (15–35) 0.275 < 0.001 0.007
Goblet cells 13.5 (10.5–19) 12.5 (10–15.5) 7.5 (5–14.25) 0.078 0.008 0.71
Mucosal gland 22.5 (17.5–32) 15.5 (10–20) 13.5 (7.5–27.5) 0.702 0.013 0.005
Inflammatory cells 12 (8.5–18.5) 29.75 (17.25–43) 63.75 (48–88.75) 0.031 < 0.001 0.002
Table 4 Immunohistochemistry results of control, CRSsNP and CRSwNP groups
Values are expressed as medians (IQR). Mann-Whitney U test was used for unpaired comparisons
CRSsNP Chronic rhinosinusitis without nasal polyps, CRSwNP Chronic rhinosinusitis with nasal polyps, LP Lamina propria, EP Epithelium
P < 0.05 was considered statistically significant. Italic P values show significant results (<0.05)
Control CRSsNP CRSwNP Control vs. CRSsNP Control vs. CRSwNP CRSwNP 
vs. CRSsNP
Total IgA LP 3 (2–4) 6.5 (5–8.5) 8 (5–13.5) < 0.001 < 0.001 0.77
IgA2 LP 0 (0–0) 1 (1–1) 1 (0–2) 0.023 < 0.001 0.721
IgA1 LP 2.5 (2–3) 6.5 (5–8.5) 6.5 (4–10) <0.001 <0.001 0.82
Total IgA EP 1 (1–1) 1 (0.5–2) 2 (1–3) 0.34 0.002 0.122
IgA2 EP 0 (0–0) 0 (0–0.5) 0 (0–1) 0.1 0.11 0.1
IgA1 EP 1 (1–1) 1 (0.5–2) 2 (1–2) 0.34 0.001 0.11
CD20 1 (1–2) 5.5 (3–8) 14 (6.5–34.5) 0.001 < 0.001 0.134
CD138 4 (2–5) 5 (2–7) 10.5 (5–33.5) 0.327 < 0.001 0.009
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of CRS. Eosinophils regulate the local inflammation 
in the sinonasal tissues of CRS patients [2]. Studies 
on eosinophil-deficient mice have demonstrated the 
important interactions of eosinophils and IgA expressing 
B cells. Hence, eosinophils can improve the development 
of IgA producing plasma cells locating in the LP [23].
In this study, total IgA and both subclasses were 
significantly elevated in LP of both CRS groups in 
comparison to controls whereas total IgA and IgA1 
were significantly increased in the epithelium of only 
CRSwNP patients. Our findings were consistent with 
Van Zele et  al. and Schleimer et  al. study who showed 
that the concentration of IgA was higher in CRSwNP 
than the other two groups [24, 25]. We also evaluated the 
IgA and related subclasses in ENP and N-ENP patients. 
Total IgA and subclasses were significantly elevated 
in LP and epithelium (except IgA1) of ENP patients in 
comparison to N-ENP patients. These findings confirmed 
the Song et  al. results in which IgA level in polyp with 
ectopic lymphoid tissues was increased in both ENP 
and N-ENP, but they did not evaluate IgA subclasses. 
Hupin et  al. showed the level of IgA1 and IgA2 mature 
transcripts were not significantly different among 
studied groups [26]. Hammarstrőm et al. explored nasal 
mucosa of controls and indicated a continuous IgA1 class 
switching. They acclaimed that  IgA1+ B cells could play 
a role as precursors of  IgA2+ B cells and according to 
the content and type of the encountered antigens in the 
sinonasal mucosa, the proportion of  IgA1+ and  IgA2+ 
plasma cells could alter among various subjects [15]. 
We demonstrated that the expression of α1GLT was 
higher than α2GLT in CRSwNP patients. This finding 
may indicate that the transcription of IgA1 was higher 
than IgA2. Further investigation showed on the contrary 
to IgA2, the protein levels of total IgA and IgA1 were 
elevated in CRSwNP patients. In Kett et  al. study, 96% 
of  IgA+ cells were IgA1 positive in nasal mucosa [27]. 
According to our results, it sounds that the distribution 
rate of IgA1 and IgA2 doesn’t show alteration in 
nasal polyps; instead, their production is increased in 
comparison to normal tissues. In agreement with Dilidaer 
et al. study, our results show that the expression of AID 
mRNA was elevated in CRSwNP patients in comparison 
to controls [28]. In this study, the expressions of µGLT, 
Iα1-Cα1 GLT, Iα2-Cα2 GLT, Iα–Cµ CT, and AID showed 
an ongoing IgA subclass switching in CRSwNP patients.
Interestingly, we found a positive correlation between 
eosinophil counts and the levels of IgA subclasses in 
CRSwNP patients. Human eosinophils express various 
IgA receptors, including FcαRI (CD89), poly Ig receptor 
(pIgR) and so on [29]. Elevated FcαRI expression has 
been frequently reported on eosinophils of allergic and 
asthmatic patients and impaired expression of FcαRI may 
result in enhanced IgA levels [30]. Altogether, further 
research is necessary to determine the functions of 
receptors related to IgA subclasses on eosinophils.
Fig. 2 The number of eosinophils showed positive significant 
correlations with the total IgA + cells (r = 0.77) (a), IgA1 + cells 
(r = 0.72) (b), and IgA2 + cells (r = 0.6) (c) in lamina propria (LP) of 
CRSwNP patients according to Spearman’s rank correlation test
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Class switching is regulated by a number of cytokines. 
TGF-β1 is a prominent cytokine, providing IgA switching 
through the regulation of germline transcripts [15]. In our 
study, although the level of TGF-β in CRSwNP patients 
decreased in comparison to the control group, which was 
not significant, this difference was significant in Bruaene 
et  al. study [31]. Responsive elements of TGF-β1 in the 
human Iα1 and Iα2 promoters have a similar structure, so 
this cytokine probably does not determine the direction 
toward IgA subclasses [32]. Hence, other prerequisite 
factors are needed. BAFF is a potent cytokine to enhance 
the induction of IgA1 and IgA2 expression and APRIL 
can only stimulate IgA2 expression [11]. It has been 
reported that BAFF is elevated in CRSwNP patients, thus 
it may be a hallmark of active IgA class switching [33, 34]. 
In our study, the expression of BAFF was significantly 
elevated in CRSwNP patients compared with controls; 
while the expression of APRIL didn’t show any significant 
difference in three groups. This is consistent with the 
study of Schleimer et al. who reported that BAFF mRNA 
may be significantly elevated in CRSwNP patients. 
Meanwhile, they showed that the expression of APRIL 
wasn’t increased in CRS patients [24]. Yon et al. showed 
that  BAFF+ cells were higher in eosinophilic CRSwNP 
group than non-eosinophilic and controls. Their 
study also showed BAFF expression was significantly 
correlated with IgA production and B cell accumulation 
[35]. He et  al. reported that the expression of APRIL in 
intestinal epithelial cells is higher than other epithelial 
cells. It may be due to the inducers of APRIL expression, 
including lipopolysaccharide (LPS) and flagellin which 
are commonly found in the intestine where they can 
stimulate TLR4 and TLR5, respectively [11]. However, 
LPS and flagellin do not alter the expression of APRIL in 
human nasal epithelial cells which predominantly express 
TLR2 and TLR3 instead [24]. Indeed, the main difference 
between BAFF and APRIL expression is defined by 
the final purpose of IgA class switching whether it is 
protective against commensal or infectious microbes 
[24].
Table 5 General histologic results of eosinophilic and non-eosinophilic CRSwNP subgroups
Values are expressed as median (IQR). Mann-Whitney U test was used for unpaired comparisons
CRSsNP Chronic rhinosinusitis without nasal polyps, ENP Eosinophilic chronic rhinosinusitis with nasal polyps, N-ENP Non-eosinophilic chronic rhinosinusitis with nasal 
polyps
P < 0.05 was considered statistically significant. Italic P values show significant results (<0.05)
ENP N‑ENP ENP vs. N‑ENP ENP vs. CRSsNP N‑ENP vs. 
CRSsNP
Neutrophils 5 (2.5–9.75) 3.5 (1–6.5) 0.267 0.005 0.2
Eosinophils 35 (24.5–45) 6 (5–7) < 0.001 < 0.001 0.347
Mononuclear cells 30 (15–33.75) 21 (15–35) 0.745 0.007 0.016
Goblet cells 7.5 (5.25–13) 6 (5–135.5) 0.673 0.1 0.152
Mucosal gland 19 (7.5–28) 12 (7.5–15) 0.239 0.5 0.437
Inflammatory cells 73 (62–101) 33.5 (31.5–54) < 0.001 < 0.001 0.152
Table 6 Immunohistochemistry results in Eosinophilic and Non-eosinophilic CRSwNP subgroups
Values are expressed as median (IQR). Mann-Whitney U test was used for unpaired comparisons
CRSsNP Chronic rhinosinusitis without nasal polyps, ENP Eosinophilic chronic rhinosinusitis with nasal polyps, N-ENP Non-eosinophilic chronic rhinosinusitis with nasal 
polyps, LP Lamina propria, EP Epithelium
P < 0.05 was considered statistically significant. Italics P values show significant results (<0.05)
ENP N‑ENP ENP vs. N‑ENP ENP vs. CRSsNP N‑ENP vs. 
CRSsNP
Total IgA LP 11 (8.5–15) 5 (3–6) < 0.001 0.002 0.007
IgA2 LP 2 (1–3) 0 (0–1) 0.003 0.053 0.11
IgA1 LP 10 (7–12.5) 4 (3–5) < 0.001 0.023 0.002
Total IgA EP 3 (1.5–3) 1 (1–2) 0.013 0.037 0.99
IgA2 EP 1 (0–1) 0 (0–0) 0.015 0.123 0.47
IgA1 EP 2 (1–2) 1 (1–2) 0.179 0.85 0.611
B cells (CD20) 21 (8–44) 9 (7–16) 0.051 0.026 0.225
Plasma cells (CD138) 25 (7–42) 6 (4–14) 0.022 0.01 0.205
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Fig. 3 The mRNA expression levels of BAFF, Iα1-Cα1 GLT, Iα2-Cα2 GLT, Iα-Cµ CT, µGLT, APRIL, CXCL13, and AID in CRSwNP, CRSsNP, and control 
groups. The data are represented by box and whisker plots, and the Kruskal–Wallis test was used for the statistical analyses. *P < 0.05; **P < 0.01 
CRSsNP chronic rhinosinusitis without nasal polyps, CRSwNP Chronic Rhinosinusitis with Nasal Polyps
Page 10 of 12Aazami et al. Allergy Asthma Clin Immunol           (2020) 16:30 
CXCL13 is an important factor that recruits B cells to 
the local inflammatory sites and it has been previously 
established to be elevated in CRSwNP patients [36]. 
IHC results indicated  CD20+ cells and  CD138+ cells 
were increased in CRSwNP patients which were 
consistent with Dilidaer et al. study [28]. We found that 
the expression of CXCL13 was significantly elevated 
in CRSwNP patients. On combination of increased 
number of B cells and the level of IgA in CRSwNP 
patients, it is possible that CXCL13 actively contributes 
to the local IgA class switching due to the recruitment 
of B cells to the inflammatory sites. Cao et al. indicated 
that the expression of CXCL13 is increased in both 
ENP and N-ENP patients. They also showed that the 
number of  CD20+ and  CD138+ cells is increased in 
both groups [37]. Future studies are needed to reveal 
how these chemokines facilitate the recruitment of B 
cells to the inflammatory sites of the nasal mucosa.
Our findings provided new evidence suggesting 
possible mechanisms in IgA subclass switching and 
correlation with eosinophil in CRSwNP patients. 
However, more studies are needed to validate the exact 
mechanisms in association with IgA and eosinophil 
activation in these patients. Furthermore, we could 
not verify the relationship between IgA class switching 
process and eosinophil in CRSsNP patients; Therefore, 
further investigations are necessary to clarify the 
impacts of IgA in CRSsNP patients. Further studies 
in this area may reveal unknown mechanisms in 
patients and can also reveal new therapeutic goals. The 
major limitation of this study was small the sample 
population.
Conclusion
In the current study, the factors involved in the promotion 
of IgA class switching in the sinonasal mucosa of CRS 
patients were evaluated. These findings showed that IgA 
subclasses were increased in the CRSwNP patients. We 
also showed that eosinophils correlated with IgA positive 
cells in the CRSwNP patients. Furthermore, BAFF, 
CXCL13, GLTs, and AID were significantly increased 
in the CRSwNP patients possibly demonstrating 
mechanisms of IgA subclass switching in CRS patients. 
Moreover, the findings showed IgA subclasses in the ENP 
Fig. 4 The protein levels of total IgA, IgA1, IgA2, and TGF-β in sinonasal tissue homogenates of CRSwNP, CRSsNP, and control groups. The 
concentrations of total IgA and IgA1 in tissue homogenates of CRSwNP patients were significantly increased in comparison to CRSsNP and control 
groups. There is no difference in the protein level of IgA2 in three groups. The data are represented by column and the Kruskal–Wallis test was used 
for the statistical analyses. *P < 0.05; **P < 0.01; ****P < 0.0001 CRSsNP chronic rhinosinusitis without nasal polyps, CRSwNP chronic rhinosinusitis with 
nasal polyps
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group were significantly higher than the N-ENP group. 
In future studies, more attention should be given to the 
relationship of IgA receptors and its signaling pathway 
with eosinophilic inflammation. In this regard, the study 
of whether the recruitment of eosinophils should be done 
by IgA or vice versa. Further studies on the role of local 
production of IgA and its relationship with pathologic 
functions of eosinophils may lead to designing novel 
inhibitors to reduce the inflammation and the ENP 
patient’s symptoms.
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